Boone, N W <br/><br/>
Less is more: a cost benefit analysis of a changed posology for nivolumab.  [electronic resource] 

 -  European journal of clinical pharmacology  May 2020 
 - 739-740 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1432-1041 
<br/><br/><label>Standard No.: </label>10.1007/s00228-020-02839-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost-Benefit Analysis<br/>Humans<br/>Neoplasms--drug therapy<br/>Nivolumab--administration & dosage